Gujarat Themis Biosyn Files Quarterly Depository Certificate and Voting Results
Gujarat Themis Biosyn filed a depository certificate for the quarter ended June 30, 2026. The company also passed a special resolution for raising funds via Qualified Institutions Placement (QIP) with 99.98% votes in favour. Promoters held 77,218,083 shares.
The approval for fundraising via QIP is a significant corporate action that can impact the company's financial structure and growth prospects. While the exact amount to be raised is not specified, the process itself suggests potential for substantial capital infusion.
The company has successfully passed a resolution for fundraising through QIP with a very high percentage of favourable votes, indicating strong shareholder confidence. The submission of the depository certificate is a routine compliance, but the QIP approval is a positive development for future growth.
Gujarat Themis Biosyn Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026. This certificate was received from MUFG lntime India Pvt. Ltd., the company's Registrar and Share Transfer Agent.
The company also disclosed voting results for a special resolution concerning raising funds through Qualified Institutions Placement (QIP). In the voting process, which included e-voting and poll, a total of 79,496,307 votes were polled out of 108,965,265 outstanding shares, representing 72.96% of the total votes. The resolution to raise funds via QIP received overwhelming support, with 79,477,366 votes in favour and only 18,941 votes against, translating to 99.98% of the votes polled in favour. Promoter and Promoter Group held 77,218,083 shares, Public Institutions held 3,221,880 shares, and Public - Non Institutions held 28,525,302 shares. The resolution was passed with the required majority, and promoters were not interested in the agenda.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.